99% Savings - Buy Just @1 Rs X
Exinia 50 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Heart Failure are some of its major therapeutic uses. Secondary and off-label uses of Exinia 50 Mg Tablet have also been mentioned below.
The correct dosage of Exinia 50 Mg Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Exinia 50 Mg Tablet have been listed ahead. Such side effects of Exinia 50 Mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Exinia 50 Mg Tablet is Safe for pregnant women and Unknown for women who are breastfeeding. In addition, Exinia 50 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Exinia 50 Mg Tablet related warnings section.
Exinia 50 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Exinia 50 Mg Tablet in conditions like Diabetes, Hyperkalemia, Kidney Disease. The section on Exinia 50 Mg Tablet contraindications lists all such conditions.
Drug reaction of Exinia 50 Mg Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Exinia 50 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Exinia 50 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Exinia 50 Mg Tablet safe for pregnant women?
Pregnant women can take Exinia without worrying about any side effects.
Is the use of Exinia 50 Mg Tablet safe during breastfeeding?
No research work has been carried out till date on effect of Exinia on breastfeeding women. So it is not known whether taking Exinia will cause side effects or not.
What is the effect of Exinia 50 Mg Tablet on the Kidneys?
Exinia has very mild side effects on the kidneys.
What is the effect of Exinia 50 Mg Tablet on the Liver?
Exinia has very mild side effects on the liver.
What is the effect of Exinia 50 Mg Tablet on the Heart?
Exinia has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Exinia 50 Mg Tablet unless your doctor advises you to do so -
Is this Exinia 50 Mg Tablet habit forming or addictive?
Exinia 50 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Exinia 50 Mg Tablet, you should not drive or work on any heavy machine, as Exinia 50 Mg Tablet can make you drowsy.
Is it safe?
There are no side effects of Exinia 50 Mg Tablet, so it is safe for use.
Is it able to treat mental disorders?
No, Exinia 50 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Exinia 50 Mg Tablet
Eating certain foods may increase the time it takes Exinia 50 Mg Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Exinia 50 Mg Tablet
Consult your doctor before consuming alcohol while taking Exinia 50 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Inspra® (eplerenone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 561
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 508-509